Premium
Identification of α‐Mangostin as an Agonist of Human STING
Author(s) -
Zhang Yibo,
Sun Zhen,
Pei Jianwen,
Luo Qinhong,
Zeng Xin,
Li Qinkai,
Yang Zhen,
Quan Junmin
Publication year - 2018
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.201800481
Subject(s) - sting , agonist , xanthone , stimulator of interferon genes , interferon , pharmacology , chemistry , biology , immunology , receptor , biochemistry , stereochemistry , innate immune system , engineering , aerospace engineering
The xanthone derivate 5′,6′‐dimethylxanthenone‐4‐acetic acid (DMXAA, also known as ASA404 or vadimezan) is a potent agonist of murine STING (stimulator of interferon genes), but cannot activate human STING. Herein we report that α‐mangostin, which bears the xanthone skeleton, is an agonist of human STING, but activates murine STING to a lesser extent. Biochemical and cell‐based assays indicate that α‐mangostin binds to and activates human STING, leading to activation of the downstream interferon regulatory factor (IRF) pathway and production of type I interferons. Furthermore, our studies show that α‐mangostin has the potential to repolarize human monocyte‐derived M2 macrophages to the M1 phenotype. The agonist effect of α‐mangostin in the STING pathway might account for its antitumor and antiviral activities.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom